Yarrow Bioscience YARW
NASDAQ YARW
$36.42 -1.51 (-3.97%)
As of: Aug 21, 2026 · 3:42 PM EDT

Yarrow Bioscience (YARW) Other Non Operating Income (2017 - 2026)

Yarrow Bioscience's (YARW) quarterly Other Non Operating Income came in at $231000.0 in Q1 2026, down 61.11% YoY from $594000.0 in Q1 2025, and down 82.23% on a QoQ basis from $1.3 million in Q2 2025.

Yarrow Bioscience (YARW) Other Non Operating Income (2017 - 2026) Analysis & Trends

Yarrow Bioscience (YARW) has 10 years of Other Non Operating Income data on file, last reported at $231000.0 in Q1 2026.

  • Quarterly Other Non Operating Income fell 61.11% year-over-year to $231000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 million (down 12.28% YoY) and the FY2025 annual result came in at $3.0 million, down 21.31% from the prior year.
  • Other Non Operating Income retreated to $231000.0 in Q1 2026, from $1.3 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $1.3 million in Q2 2025 to a low of -$3000.0 in Q1 2022.
  • A 5-year average of $513866.7 and a median of $280000.0 in 2023 frame the typical range for Other Non Operating Income.
  • Annual changes were most pronounced in 2023 — Other Non Operating Income soared 8866.67% — and 2026, when it plunged 61.11%.
  • Tracing YARW's Other Non Operating Income over 5 years: stood at $236000.0 in 2022, then jumped by 188.14% to $680000.0 in 2023, then grew by 11.76% to $760000.0 in 2024, then surged by 71.05% to $1.3 million in 2025, then tumbled by 82.23% to $231000.0 in 2026.
  • The last three Other Non Operating Income figures came in at $231000.0 (Q1 2026), $1.3 million (Q2 2025), and $594000.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Yarrow Bioscience 31.25 Mn 8.33 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 203,000.00
Mar 31, 2026 231,000.00
Jun 30, 2025 1.30 Mn
Mar 31, 2025 594,000.00
Dec 31, 2024 760,000.00
Sep 30, 2024 934,000.00
Jun 30, 2024 1.00 Mn
Mar 31, 2024 1.14 Mn
Dec 31, 2023 680,000.00
Sep 30, 2023 163,000.00
Jun 30, 2023 280,000.00
Mar 31, 2023 263,000.00
Dec 31, 2022 236,000.00
Sep 30, 2022 78,000.00
Jun 30, 2022 52,000.00
Mar 31, 2022 -3,000.00
Dec 31, 2021 26,000.00
Sep 30, 2021 -35,000.00
Jun 30, 2021 -69,000.00
Mar 31, 2021 -57,000.00